Biotronik launched its Lumax 540 series at Cardiostim, in June. This technologically advanced series, which includes implantable cardioverter defibrillators (ICDs) and a cardiac resynchronization therapy defibrillator (CRT-D), has many industry-leading features to save and enhance patients’ lives. This, together with Biotronik Home Monitoring, enables continuous automatic daily data transmission of the patient’s cardiovascular status. The information is available to the physicians online allowing them to continuously check their patients’ cardiac and device status.
“Lumax 540 has an excellent range of high quality features that allow physicians to tailor the treatment to our individual patients. Coupled with the Biotronik Home Monitoring technologies, we are able to access patient data online anywhere in the world” said Professor Panos Vardas, Cardiology Department, University Hospital, Heraklion, Crete, Greece.
The Lumax 540 series has features to ensure that patients receive the appropriate therapy adapted to their individual needs while maintaining optimal safety. SelectSense has various pre-settings to adapt sensing characteristics to individual patient needs to ensure accurate arrhythmia detection. The Defibrillation Threshold Manager ensures that life-saving shock therapy is delivered successfully. In addition, the Automatic Threshold Monitor performs daily threshold measurements. The Heart Failure Monitor detects changes in heart failure conditions with an extensive range of clinical predictors. A comprehensive set of diagnostic capabilities included in the Lumax 540 devices help physicians with the identification of clinically relevant atrial fibrillation and the early detection of worsening heart failure status.
Biotronik’s extensive engineering research has produced industry-leading batteries which extend the life of the Lumax 540 devices up to 10 years. “Patients could benefit from this extended battery life due to the need for fewer device replacements over time, thereby improving quality of life and at the same time helping to reduce healthcare costs. In fact, we are so confident in the advantages of our new battery technology, Biotronik will further extend our warranty for our Lumax 540 ICDs”, commented Marlou Janssen, Vice President Global Marketing and Sales, Cardiac Rhythm Management, Biotronik.
